GB0320793D0 - Chemical process - Google Patents
Chemical processInfo
- Publication number
- GB0320793D0 GB0320793D0 GB0320793A GB0320793A GB0320793D0 GB 0320793 D0 GB0320793 D0 GB 0320793D0 GB 0320793 A GB0320793 A GB 0320793A GB 0320793 A GB0320793 A GB 0320793A GB 0320793 D0 GB0320793 D0 GB 0320793D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical process
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0320793A GB0320793D0 (en) | 2003-09-05 | 2003-09-05 | Chemical process |
PCT/GB2004/003720 WO2005023783A1 (en) | 2003-09-05 | 2004-09-01 | Process for the manufacture of gefitinib |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0320793A GB0320793D0 (en) | 2003-09-05 | 2003-09-05 | Chemical process |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0320793D0 true GB0320793D0 (en) | 2003-10-08 |
Family
ID=29226532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0320793A Ceased GB0320793D0 (en) | 2003-09-05 | 2003-09-05 | Chemical process |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0320793D0 (en) |
WO (1) | WO2005023783A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1300118C (en) * | 2005-08-25 | 2007-02-14 | 江苏吴中苏药医药开发有限责任公司 | Preparation method of 4-(3-chlor-4-fluorobenzeneamidocyanogen)-7-methoxy-6-(3-morpholine oxypropyl)quinazoline |
JP2010524909A (en) | 2007-04-16 | 2010-07-22 | シプラ・リミテッド | Method for producing gefitinib |
WO2010061400A1 (en) * | 2008-11-03 | 2010-06-03 | Natco Pharma Limited | A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts |
BRPI1013854A2 (en) * | 2009-04-23 | 2017-05-16 | Astrazeneca Ab | process for preparing compound, compound, and salt of a compound |
CN102120731B (en) * | 2010-01-09 | 2015-01-07 | 浙江华海药业股份有限公司 | Novel method for preparing 4-(3-chlorine-4-fluorophenylamino)-7-methoxyl-6-(3-morpholinepropoxy)quinazoline |
PT2729173T (en) | 2011-07-06 | 2016-09-22 | Sykehuset Sorlandet Hf | Egfr targeted therapy |
CN102659716B (en) * | 2012-05-02 | 2014-09-10 | 北京国联诚辉医药技术有限公司 | Method for preparing 4-methoxyl-2-amido-3-[3-(4-morpholino) oxypropyl]cyanophenyl and process for preparing gefitinib |
KR101457453B1 (en) * | 2012-05-31 | 2014-11-04 | 주식회사 종근당 | Process for preparing gefitinib and an intermediate used for preparing thereof |
CN103570633B (en) * | 2012-07-27 | 2015-08-05 | 中国科学院广州生物医药与健康研究院 | The preparation method of Gefitinib |
JP2016507493A (en) | 2012-12-21 | 2016-03-10 | スィーケフス ソールラン ホーエフ | EGFR targeted treatment of neuropathy and pain |
CN103739558B (en) * | 2013-09-23 | 2016-05-04 | 南京优科生物医药研究有限公司 | A kind of preparation method of Gefitinib known impurities |
CN105968103B (en) * | 2016-07-18 | 2018-11-27 | 山东罗欣药业集团恒欣药业有限公司 | The synthetic method of anti-tumor drug Afatinib |
CN107698523A (en) * | 2017-09-26 | 2018-02-16 | 盐城师范学院 | A kind of preparation method of tyrosine kinase inhibitor Gefitinib |
CN109384747A (en) * | 2018-10-26 | 2019-02-26 | 苏州立新制药有限公司 | Gefitinib related substances and its preparation and detection method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US6384223B1 (en) * | 1998-07-30 | 2002-05-07 | American Home Products Corporation | Substituted quinazoline derivatives |
PL360439A1 (en) * | 2000-06-28 | 2004-09-06 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
-
2003
- 2003-09-05 GB GB0320793A patent/GB0320793D0/en not_active Ceased
-
2004
- 2004-09-01 WO PCT/GB2004/003720 patent/WO2005023783A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005023783A1 (en) | 2005-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0324791D0 (en) | Chemical process | |
GB0312896D0 (en) | Chemical process | |
TWI316058B (en) | Chemical process | |
IL165286A0 (en) | Chemical process | |
GB0306432D0 (en) | Process | |
GB0303659D0 (en) | Process | |
GB0320793D0 (en) | Chemical process | |
GB0218041D0 (en) | Chemical process | |
GB0307259D0 (en) | Process | |
GB0229803D0 (en) | Chemical process | |
GB0216412D0 (en) | Chemical process | |
GB0210370D0 (en) | Chemical process | |
GB0222833D0 (en) | Chemical process | |
GB0313920D0 (en) | Chemical process | |
GB0302648D0 (en) | Chemical process | |
GB0308672D0 (en) | Process | |
GB0300733D0 (en) | Process | |
GB0313909D0 (en) | Chemical process | |
GB0313908D0 (en) | Chemical process | |
GB0313917D0 (en) | Chemical process | |
GB0313911D0 (en) | Chemical process | |
GB0320795D0 (en) | Chemical process | |
GB0313919D0 (en) | Chemical process | |
GB0313910D0 (en) | Chemical process | |
GB0324545D0 (en) | Chemical process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |